These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 21177701)
1. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701 [TBL] [Abstract][Full Text] [Related]
2. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266 [TBL] [Abstract][Full Text] [Related]
4. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females. Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646 [TBL] [Abstract][Full Text] [Related]
5. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts. Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640 [TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. White K; Loughlin L; Maqbool Z; Nilsen M; McClure J; Dempsie Y; Baker AH; MacLean MR Physiol Genomics; 2011 Apr; 43(8):417-37. PubMed ID: 21303932 [TBL] [Abstract][Full Text] [Related]
7. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension. Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308 [TBL] [Abstract][Full Text] [Related]
8. Serotonin and pulmonary hypertension--from bench to bedside? MacLean MR; Dempsie Y Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424 [TBL] [Abstract][Full Text] [Related]
9. [Serotonin hypothesis and pulmonary artery hypertension]. Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-361-3p suppresses serotonin-induced proliferation in human pulmonary artery smooth muscle cells by targeting SERT. Zhang Y; Chen Y; Chen G; Zhou Y; Yao H; Tan H Cell Mol Biol Lett; 2020; 25():45. PubMed ID: 33061998 [TBL] [Abstract][Full Text] [Related]
12. A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension. Wallace E; Morrell NW; Yang XD; Long L; Stevens H; Nilsen M; Loughlin L; Mair KM; Baker AH; MacLean MR Am J Respir Crit Care Med; 2015 Jun; 191(12):1432-42. PubMed ID: 25871906 [TBL] [Abstract][Full Text] [Related]
13. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393 [TBL] [Abstract][Full Text] [Related]
14. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000 [TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension. Liu A; Tian L; Golob M; Eickhoff JC; Boston M; Chesler NC Hypertension; 2015 Nov; 66(5):1082-8. PubMed ID: 26418020 [TBL] [Abstract][Full Text] [Related]
16. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice. Huh JW; Kim SY; Lee JH; Lee YS Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997 [TBL] [Abstract][Full Text] [Related]
17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [TBL] [Abstract][Full Text] [Related]
18. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538 [TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model. de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116 [TBL] [Abstract][Full Text] [Related]